News & Updates

Severe asthma patients on biologics predisposed to severe COVID-19

03 Mar 2021

Patients with severe asthma receiving treatment with biologics are more likely to contract COVID-19 and develop a severe course as compared with the general population, a study has found.

Severe asthma patients on biologics predisposed to severe COVID-19

03 Mar 2021

CUHK & HKU surveys: One-third to half of respondents not willing to receive COVID-19 vaccine

03 Mar 2021 by

As the Hong Kong government launches a territory-wide coronavirus disease 2019 (COVID-19) vaccination programme, the Chinese University of Hong Kong (CUHK) and the University of Hong Kong (HKU) have shared findings of their independent telephone surveys gauging public views of the programme.

CUHK & HKU surveys: One-third to half of respondents not willing to receive COVID-19 vaccine

03 Mar 2021

PrEP recommended for MSM who seek postexposure prophylaxis

02 Mar 2021

Around 2 percent of people seeking post-exposure prophylaxis (PEP) eventually test positive for HIV within 4 years, a recent study has found. This trend is particularly pronounced among men who have sex with men (MSM), strongly suggesting the potential for the early consideration of pre-exposure prophylaxis (PrEP) after a first episode of PEP.

PrEP recommended for MSM who seek postexposure prophylaxis

02 Mar 2021

GI symptoms tied to lower mortality in COVID-19

02 Mar 2021

Patients with the novel coronavirus disease (COVID-19) are prone to gastrointestinal (GI) symptoms, which appears to predict a better prognosis, suggests a single-centre cohort study in Northern Italy.

GI symptoms tied to lower mortality in COVID-19

02 Mar 2021

Even at suboptimal uptake, PrEP effective at preventing HIV in teen MSM

28 Feb 2021

A recent modelling study has found that expanding current pre-exposure prophylaxis (PrEP) programmes and improving adherence rates can substantially lower HIV incidence among men who have sex with men (MSM).

Even at suboptimal uptake, PrEP effective at preventing HIV in teen MSM

28 Feb 2021

COVID-19 vaccines vs new variants: Are we protected?

27 Feb 2021 by

While more and more COVID-19 vaccines are getting rolled out globally, the world is also seeing new variants of SARS-CoV-2 emerging. How effective will the vaccines work against these new variants is largely unknown. Billions worldwide are watching closely and bracing themselves on how this might unfold.

COVID-19 vaccines vs new variants: Are we protected?

27 Feb 2021

Risk for thrombotic events higher after respiratory infections needing hospitalization

27 Feb 2021

Being hospitalized for respiratory infections heightens the risk of myocardial infarction (MI) and venous thromboembolism (VTE), especially in the first 30 days after discharge, a recent study has found.

Risk for thrombotic events higher after respiratory infections needing hospitalization

27 Feb 2021

Severe/critical COVID-19 may up perinatal risk

26 Feb 2021 by

Critical or severe COVID-19 disease could raise the risk of negative perinatal outcomes in pregnant women, according to an observational study from the US.

Severe/critical COVID-19 may up perinatal risk

26 Feb 2021

Classic trio of COVID-19 symptoms miss about 30 percent of cases

26 Feb 2021 by

The triad of symptoms—fever, coughs, and anosmia/aguesia—used to screen patients for lab testing for the novel coronavirus disease (COVID-19) may be underpowered, according to a new study. Instead, additional symptom combinations may help maximize case capture and resource efficiency.

Classic trio of COVID-19 symptoms miss about 30 percent of cases

26 Feb 2021

Unrestricted DAA use could reduce HCV incidence in HIV

25 Feb 2021 by

Unrestricted access to direct-acting antivirals (DAAs) for hepatitis C virus (HCV) infection in individuals with HIV led to a substantial reduction in HCV incidence, particularly in the key subgroup of men who have sex with men (MSM), according to a retrospective Dutch study.

Unrestricted DAA use could reduce HCV incidence in HIV

25 Feb 2021

News & Updates

Filter by Specialty:

Specialty:

Severe asthma patients on biologics predisposed to severe COVID-19

Severe asthma patients on biologics predisposed to severe COVID-19

CUHK & HKU surveys: One-third to half of respondents not willing to receive COVID-19 vaccine

CUHK & HKU surveys: One-third to half of respondents not willing to receive COVID-19 vaccine

PrEP recommended for MSM who seek postexposure prophylaxis

PrEP recommended for MSM who seek postexposure prophylaxis

GI symptoms tied to lower mortality in COVID-19

GI symptoms tied to lower mortality in COVID-19

Even at suboptimal uptake, PrEP effective at preventing HIV in teen MSM

Even at suboptimal uptake, PrEP effective at preventing HIV in teen MSM

COVID-19 vaccines vs new variants: Are we protected?

COVID-19 vaccines vs new variants: Are we protected?

Risk for thrombotic events higher after respiratory infections needing hospitalization

Risk for thrombotic events higher after respiratory infections needing hospitalization

Severe/critical COVID-19 may up perinatal risk

Severe/critical COVID-19 may up perinatal risk

Classic trio of COVID-19 symptoms miss about 30 percent of cases

Classic trio of COVID-19 symptoms miss about 30 percent of cases

Unrestricted DAA use could reduce HCV incidence in HIV

Unrestricted DAA use could reduce HCV incidence in HIV